A Probiotic Agent for Regulating Intestinal Hormone GLP-1 Levels and its Application
Abstract
The invention pertains to a probiotic agent designed to modulate the gut hormone GLP-1 levels, encompassing the Lacticaseibacillus rhamnosus LRa05 strain (CGMCC No.1.12734) and its application in obesity treatment. The LRa05 strain significantly enhances GLP-1 expression in intestinal endocrine cells, reducing body weight and serum ALT and AST levels in obese individuals....
0 Comments
0 Shares
1834 Views
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek